Richard I. Steinhart, Chief Financial Officer at BioXcel Therapeutics, Inc. (BTAI), sold 7,500 shares at $48.15 ($361K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $361k BTAI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.15 | 3,750 | $181K | 50.0% |
| 2 | $48.15 | 3,750 | $181K | 50.0% |
| Total | $48.15 avg | 7,500 | $361K | 100% |
| Filing → |
| BTAI | SELL | 2024-10-03 | $4K | — | Filing → |
| BTAI | SELL | 2024-09-17 | $246 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $469 | — | Filing → |